STAT1 and infection: A previously published case study reported successful reduction of anti-IFN-γ-auto-Abs and improved IFN-γ-induced STAT-1 phosphorylation after BTZ administration in patients with refractory infections after rituximab treatment, which resulted in a better clinical and radiological outcome [34].